Leadership & Pay ·
Director Edward Mathers resigns from Senti Biosciences Board effective immediately
SNTISenti Biosciences Holdings, Inc.
Edward Mathers notified the Board of Directors on October 27, 2026, of his decision to resign from the board and all committee positions, effective immediately. The company thanked him for his service. Additionally, the filing confirms the record date of October 30, 2026, for a previously announced distribution of contingent value rights (CVRs) related to the merger closing on October 21, 2026. Senti Biosciences Holdings operates in the biotechnology sector, focusing on synthetic biology and cell therapy.